🇺🇸 FDA
Patent

US 7078525

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

granted A61PA61P19/02A61P25/00

Quick answer

US patent 7078525 (Pyrazolopyrimidines as cyclin dependent kinase inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmacopeia Drug Discovery, Inc.
Grant date
Tue Jul 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P19/02, A61P25/00, A61P25/28, A61P29/00